MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

23 Jan 2024 Evaluate
The revenue slipped marginally during the December 2023 quarter. A decline of about Rs. 1613.35 millions was observed as compared to Rs. 1687.92 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 207.19  millions from Rs. 292.80 millions ,decline by -29.24%.A decline of 365.56 millions was observed in the OP in the quarter ended December 2023 from 448.84 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1613.35 1687.92 -4.42 4416.42 4549.21 -2.92 5983.40 6363.57 -5.97
Other Income 78.97 114.23 -30.87 250.38 442.88 -43.47 507.66 326.28 55.59
PBIDT 365.56 448.84 -18.55 1070.56 1235.31 -13.34 1409.21 1418.26 -0.64
Interest 17.88 12.03 48.63 42.75 50.84 -15.91 100.57 43.24 132.59
PBDT 347.68 436.81 -20.40 1027.81 1184.47 -13.23 1308.64 1402.47 -6.69
Depreciation 62.48 37.90 64.85 172.90 111.99 54.39 151.73 138.47 9.58
PBT 285.20 398.91 -28.51 854.91 1072.48 -20.29 1156.91 1264.00 -8.47
TAX 78.01 106.11 -26.48 233.85 278.77 -16.11 302.14 337.36 -10.44
Deferred Tax 13.84 -12.71 -208.89 22.13 -17.41 -227.11 -42.10 7.68 -648.18
PAT 207.19 292.80 -29.24 621.06 793.71 -21.75 854.77 926.64 -7.76
Equity 104.69 104.15 0.52 104.69 104.15 0.52 104.15 103.68 0.45
PBIDTM(%) 22.66 26.59 -14.79 24.24 27.15 -10.73 23.55 22.29 5.68
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..